@inproceedings{inproceedings, title  = {{A randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO.}},

 url = {{}},

 year = {{2023}},

 month = {{1}},

 author = {{Griffiths GO and Griffiths D and Eminton Z and Hill K and Poile C and Nye M and Cave J and Danson S and Toy E and Jain P and Steele N et al}},

 volume = {{41}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{16}},

 note = {{Accessed on 2025/01/03}}}